Mark Thies
Analyst · Sidoti
Thanks, Dennis. Good morning, everyone, and just to keep the positive energy of this call going. The Blackhawks won their third straight last night, and Tyler Johnson, a local Spokane kid scored the game tie-in goal with less than a minute to go and scored the only goal in the shootout. So the Blackhawks beat the goal, the nice three to two, so a little positivity. We are still in the third place in The Connor Bedard lottery sweepstakes, which were not very good this year. Our consolidated earnings on the other hand were good this year, and they were largely, as Dennis said, primarily due to our other businesses. Our other businesses contributed $0.41 per share in 2022 compared to $0.21 in 2021. The majority of these earnings were really the result of the significant increase in the fair value of an investment in the biotechnology company, a bioscience company. Our original investment in this company was for the development of biofuels, really to tie to our core, but it was later acquired and the focus shifted to biotechnology. Their patented biologic drug platform accelerates the time to market for orally administrative antibody drugs and has advanced through testing stages. As a result, the value of this investment has increased significantly, and they are in various stages of clinical trials right now, and we don't expect results really until the end of 2024. So there's going to be some time before we have significant updates on that as our expectation. For 2022 Avista Utilities contributed to $1.61 per share compared to a $1.79 in 2021. This was, as Dennis mentioned, just slightly below our expectations, and was a result of extreme volatility in the power and natural gas markets across the west, leading to higher power supply costs. In December, we observed prices as much as 5x to 8x higher than normal, along with colder temperatures throughout November and December, and that's the coldest we've seen in over 20 years. This volatility led to significant margin calls, which impacted our available liquidity and required us to secure additional short-term borrowing arrangements, which we did in the fourth quarter. Avista Utilities earnings reflect the result of the combined pressures of just the power supply costs that I talked about, interest expense, higher interest expense, and inflation. The energy recovery mechanism in Washington was a pre-tax expense of $10.9 million compared to a pre-tax expense of $7.7 million in the prior year. So our total deferred power costs exceed $30 million in 2022, and as a result, we expect to file with the Washington Commission in April to begin recovering these costs in July of 2023. With respect to our capital expenditures, we continue to invest the necessary capital in our utility infrastructure to maintain a safe and reliable, standard of service as we always expect. In that, we expect those capital expenditures to be $475 million annually through 2025. We expect [indiscernible] AEL&P capital to be $16 million in 2023, $14 million in 2024 and 16 million again in 2025. As I talked about liquidity a little bit earlier. In 2022, we issued $400 million of long-term debt and $138 million of common stock. We had a significant about $250 million maturity in there too, just to give the difference. In the fourth quarter, we experienced significant increases in commodity prices and the need for additional liquidity, as I mentioned earlier, but we increased our short-term borrowing capacity by $300 million, bringing our total capacity to $700 million. As of 12/31, we had $517 million outstanding under these facilities, so we had a $183 million of available liquidity at year-end. In 2023, we expect to reduce our short-term borrowings. In part, we expect to increase operating revenues resulting from recovery of some of those deferred power and natural gas costs, a return of margin deposits made with counterparties, and we expect to issue $200 million in long-term debt and up to $120 million of common stock to fund planned expenditures and reduce our short-term borrowings. We expect to increase our capacity in our $400 million revolving credit facility from $400 million to $500 million in the second quarter. AEL&P also has $25 million of available liquidity under its committed line of credit and that expires in November 2024. I want to give a little bit of discussion on our earnings guidance. As Dennis mentioned, we confirmed our 2023 earnings guidance with a range of $2.27 to $2.47 per diluted share. Our guidance assumes timely and appropriate rate relief in all of our jurisdictions. And as Dennis mentioned, we recently filed a multi-year plan in Idaho. Constructive outcomes in these cases are key to our success, as is the ongoing management of our costs. We expect Avista Utilities to contribute in the range of $2.15 to $2.31 per diluted share. The midpoint of our guidance does not include any expense or benefit under the energy recovery mechanism, and we expect to be within the deadband, the $4 million on either side of the midpoint with an increase in earnings of $0.03 per diluted share. We expect to manage our costs, as I mentioned earlier, that's part of it to an increase of 2% in O&M in 2023. Our 2023 earnings guidance reflects unrecovered structural costs estimated to reduce our return on equity by approximately 70 basis points, as well as continued regulatory timing lag that we're working to reduce that reduces our return on equity by approximately 80 basis points. So this results in an expected return on equity for Avista Utilities of approximately 7.9% in 2023. We expect AEL&P to contribute in the range of $0.08 to $0.10 per diluted share. And our outlook there for Avista Utilities and AEL&P continues to include normal precipitation and hydroelectric generation for the year. We expect our other businesses to contribute $0.04 to $0.06, and I know this may sound a little bit, we've had two years of significant earnings in those, but those are – we don't predict the valuations of some of these companies. We just continue to watch as they grow and we'll record the results as they occur. So we expect that from a general perspective, $0.04 to $0.06 per share is what we are putting out in our guidance. Our guidance also generally only includes normal operating conditions and does not include any unusual or non-recurring items until the effects of those are known and certain. I'll now turn the call back over to Stacey.